{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:24Z","timestamp":1786979964540,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00296-021-04997-y","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T06:23:20Z","timestamp":1632291800000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and\/or anakinra treatment"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-6196","authenticated-orcid":false,"given":"Yusuf","family":"Karabulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-304X","authenticated-orcid":false,"given":"Halise Hande","family":"Gezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-2788","authenticated-orcid":false,"given":"Mehmet Tuncay","family":"Duru\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"4997_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10067-014-2772-2","volume":"35","author":"ZB \u00d6z\u00e7akar","year":"2016","unstructured":"\u00d6z\u00e7akar ZB, \u00d6zdel S, Y\u0131lmaz S, Kurt-\u015e\u00fck\u00fcr ED, Ekim M, Yal\u00e7\u0131nkaya F (2016) Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. Clin Rheumatol 35:441\u2013446. https:\/\/doi.org\/10.1007\/s10067-014-2772-2","journal-title":"Clin Rheumatol"},{"key":"4997_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/1744666X.2017.1313116","volume":"13","author":"H Ozdogan","year":"2017","unstructured":"Ozdogan H, Ugurlu S (2017) Canakinumab for the treatment of familial Mediterranean fever. Expert Rev Clin Immunol 13:393\u2013404. https:\/\/doi.org\/10.1080\/1744666X.2017.1313116","journal-title":"Expert Rev Clin Immunol"},{"key":"4997_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","volume":"41","author":"U Meinzer","year":"2011","unstructured":"Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kon\u00e9-Paut I (2011) Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 41:265\u2013271. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.11.003","journal-title":"Semin Arthritis Rheum"},{"key":"4997_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.berh.2016.09.001","volume":"30","author":"A G\u00fcl","year":"2016","unstructured":"G\u00fcl A (2016) Approach to the patients with inadequate response to colchicine in familial Mediterranean fever. Best Pract Res Clin Rheumatol 30:296\u2013303. https:\/\/doi.org\/10.1016\/j.berh.2016.09.001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4997_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00296-019-04366-w","volume":"40","author":"S Eren Akarcan","year":"2020","unstructured":"Eren Akarcan S, Dogantan S, Edeer Karaca N, Aksu G, Kutukculer N (2020) Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review. Rheumatol Int 40:161\u2013168. https:\/\/doi.org\/10.1007\/s00296-019-04366-w","journal-title":"Rheumatol Int"},{"key":"4997_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/RHU.0000000000000873","volume":"26","author":"H Babaoglu","year":"2020","unstructured":"Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R, Ozturk MA, Goker B, Tufan A, Haznedaroglu S (2020) Effectiveness of canakinumab in colchicine- and anakinra-resistant or -intolerant adult familial Mediterranean fever patients: a single-center real-life study. J Clin Rheumatol 26:7\u201313. https:\/\/doi.org\/10.1097\/RHU.0000000000000873","journal-title":"J Clin Rheumatol"},{"key":"4997_CR7","first-page":"97","volume":"36","author":"A Erden","year":"2018","unstructured":"Erden A, Batu ED, Sar\u0131 A et al (2018) Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? Clin Exp Rheumatol 36:97\u2013102","journal-title":"Clin Exp Rheumatol"},{"key":"4997_CR8","first-page":"198","volume":"119","author":"M Jesenak","year":"2018","unstructured":"Jesenak M, Hrubiskova K, Kapustova L, Kostkova M, Banovcin P (2018) Canakinumab as monotherapy for treatment of familial Mediterranean fever\u2014first report in Central and Eastern Europe region. Bratisl Lek Listy 119:198\u2013200","journal-title":"Bratisl Lek Listy"},{"key":"4997_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen S, Demirkaya E, Erer B et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644\u2013651. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208690","journal-title":"Ann Rheum Dis"},{"key":"4997_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","volume":"10","author":"G Nuki","year":"2008","unstructured":"Nuki G (2008) Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep 10:218\u2013227. https:\/\/doi.org\/10.1007\/s11926-008-0036-3","journal-title":"Curr Rheumatol Rep"},{"key":"4997_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1568010053622984","volume":"4","author":"C Cerquaglia","year":"2005","unstructured":"Cerquaglia C, Diaco M, Nucera G, La Regina M, Montalto M, Manna R (2005) Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. Curr Drug Targets Inflamm Allergy 4:117\u2013124. https:\/\/doi.org\/10.2174\/1568010053622984","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"4997_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1096-8628(19980113)75:2<216::AID-AJMG20>3.0.CO;2-R","volume":"75","author":"E Pras","year":"1998","unstructured":"Pras E, Livneh A, Balow JE et al (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216\u2013219","journal-title":"Am J Med Genet"},{"key":"4997_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/archinte.1958.00260190052007","volume":"102","author":"H Heller","year":"1958","unstructured":"Heller H, Sohar E, Sherf L (1958) Familial Mediterranean fever. AMA Arch Intern Med 102:50\u201371. https:\/\/doi.org\/10.1001\/archinte.1958.00260190052007","journal-title":"AMA Arch Intern Med"},{"key":"4997_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","volume":"43","author":"E Sohar","year":"1967","unstructured":"Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43:227\u2013253. https:\/\/doi.org\/10.1016\/0002-9343(67)90167-2","journal-title":"Am J Med"},{"key":"4997_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5152\/eurjrheum.2019.18190","volume":"6","author":"A Berdeli","year":"2019","unstructured":"Berdeli A, \u015eenol \u00d6, Talay G (2019) Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine. Eur J Rheumatol 6:85\u201388. https:\/\/doi.org\/10.5152\/eurjrheum.2019.18190","journal-title":"Eur J Rheumatol"},{"key":"4997_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/annrheumdis-2016-eular.3617","volume":"75","author":"F De Benedetti","year":"2016","unstructured":"De Benedetti F, Ant\u00f3n J, Gattorno M et al (2016) THU0569 pharmacokinetics and pharmacodynamics of canakinumab in patients with autoinflammatory periodic fever syndromes (colchicine resistant FMF, HIDS\/MKD and TRAPS). Ann Rheum Dis 75:397\u2013398. https:\/\/doi.org\/10.1136\/annrheumdis-2016-eular.3617","journal-title":"Ann Rheum Dis"},{"key":"4997_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/14397595.2016.1194510","volume":"27","author":"O Kucuksahin","year":"2017","unstructured":"Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S (2017) Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever. Mod Rheumatol 27:350\u2013355. https:\/\/doi.org\/10.1080\/14397595.2016.1194510","journal-title":"Mod Rheumatol"},{"key":"4997_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3899\/jrheum.160518","volume":"44","author":"K Laskari","year":"2017","unstructured":"Laskari K, Boura P, Dalekos GN et al (2017) Longterm beneficial effect of canakinumab in colchicine-resistant familial Mediterranean fever. J Rheumatol 44:102\u2013109. https:\/\/doi.org\/10.3899\/jrheum.160518","journal-title":"J Rheumatol"},{"key":"4997_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/art.39995","volume":"69","author":"I Ben-Zvi","year":"2017","unstructured":"Ben-Zvi I, Kukuy O, Giat E et al (2017) Anakinra for colchicine-resistant familial mediterranean fever: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol (Hoboken, NJ) 69:854\u2013862. https:\/\/doi.org\/10.1002\/art.39995","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"4997_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3389\/fimmu.2020.00971","volume":"11","author":"V Hentgen","year":"2020","unstructured":"Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S (2020) The use of Interleukine-1 inhibitors in familial Mediterranean fever patients: a narrative review. Front Immunol 11:971. https:\/\/doi.org\/10.3389\/fimmu.2020.00971","journal-title":"Front Immunol"},{"key":"4997_CR21","doi-asserted-by":"crossref","unstructured":"Druyan A, Giat E, Livneh A, Grossman C, Ben-Zvi I, Lidar M (2021) Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab. Clin Exp Rheumatol [published online ahead of print, 2021 Jul 22]","DOI":"10.55563\/clinexprheumatol\/rrr9zd"},{"key":"4997_CR22","doi-asserted-by":"crossref","unstructured":"Atas N, Eroglu GA, Sodan HN et al (2021) Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients Clin Exp Rheumatol [published online ahead of print, 2021 Jun 21]","DOI":"10.55563\/clinexprheumatol\/815tdt"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04997-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T17:42:07Z","timestamp":1673286127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04997-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4997"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04997-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval was taken from the Marmara University Ethics Committee on 09. 2020. The protocol number was 1297.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects before enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}